Home / Japan / Nxera Pharma Co.,Ltd.
Nxera Pharma Co.,Ltd.
Short position disclosed on November 2, 2026. JPX register read on November 4, 2026.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Linden Capital L.P. | 2.65% | new | November 2, 2026 | |
| Barclays Capital Securities Ltd | 1.10% | +0.15 pt | October 30, 2026 | |
| BNP Paribas Financial Markets SNC | 0.92% | new | October 30, 2026 | |
| Nomura International plc | 0.80% | new | November 2, 2026 | |
| UBS AG | 0.74% | new | October 30, 2026 | |
| Goldman Sachs International | 0.70% | new | October 30, 2026 |
Get the moves on Nxera Pharma Co.,Ltd. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 2, 2026 | Linden Capital L.P. | 2.65% | still open |
| November 2, 2026 | Nomura International plc | 0.80% | still open |
| October 30, 2026 | Barclays Capital Securities Ltd | 1.10% | still open |
| October 30, 2026 | BNP Paribas Financial Markets SNC | 0.92% | still open |
| October 30, 2026 | Nomura International plc | 0.76% | |
| October 30, 2026 | UBS AG | 0.74% | still open |
| October 30, 2026 | Goldman Sachs International | 0.70% | still open |
| October 29, 2026 | Linden Capital L.P. | 2.85% | |
| October 29, 2026 | Goldman Sachs International | 0.87% | |
| October 28, 2026 | Linden Capital L.P. | 2.71% | |
| October 28, 2026 | BNP Paribas Financial Markets SNC | 0.86% | |
| October 28, 2026 | UBS AG | 0.81% | |
| October 27, 2026 | Barclays Capital Securities Ltd | 1.07% | |
| October 27, 2026 | UBS AG | 0.79% | |
| October 26, 2026 | Linden Capital L.P. | 1.91% | |
| October 26, 2026 | UBS AG | 0.80% | |
| October 26, 2026 | BNP Paribas Financial Markets SNC | 0.72% | |
| October 26, 2026 | Goldman Sachs International | 0.72% | |
| October 22, 2026 | Barclays Capital Securities Ltd | 1.10% | |
| October 22, 2026 | UBS AG | 0.74% | |
| October 22, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.43% | |
| October 21, 2026 | Linden Capital L.P. | 1.86% | |
| October 21, 2026 | Barclays Capital Securities Ltd | 1.08% | |
| October 21, 2026 | Goldman Sachs International | 0.66% | |
| October 21, 2026 | UBS AG | 0.64% | |
| October 21, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.52% | |
| October 19, 2026 | UBS AG | 0.52% | |
| October 16, 2026 | BNP Paribas Financial Markets SNC | 0.69% | |
| October 15, 2026 | Barclays Capital Securities Ltd | 1.11% | |
| October 15, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.64% | |
| October 14, 2026 | Barclays Capital Securities Ltd | 1.06% | |
| October 8, 2026 | Barclays Capital Securities Ltd | 0.90% | |
| October 8, 2026 | BNP Paribas Financial Markets SNC | 0.70% | |
| October 7, 2026 | BNP Paribas Financial Markets SNC | 0.69% | |
| October 6, 2026 | Barclays Capital Securities Ltd | 0.82% | |
| October 6, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.72% | |
| October 6, 2026 | BNP Paribas Financial Markets SNC | 0.71% | |
| October 5, 2026 | Goldman Sachs International | 0.76% | |
| October 1, 2026 | BNP Paribas Financial Markets SNC | 0.69% | |
| October 1, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.68% | |
| September 30, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.70% | |
| September 30, 2026 | UBS AG | 0.69% | |
| September 29, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.66% | |
| September 28, 2026 | UBS AG | 0.70% | |
| September 28, 2026 | Goldman Sachs International | 0.69% | |
| September 24, 2026 | Barclays Capital Securities Ltd | 0.71% | |
| September 24, 2026 | Goldman Sachs International | 0.71% | |
| September 24, 2026 | UBS AG | 0.67% | |
| September 18, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.72% | |
| September 18, 2026 | UBS AG | 0.59% |
Download 114 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- FLIGHT SOLUTIONS Inc. 12.10% of the capital sold short
- Datasection Inc. 11.70% of the capital sold short
- QD Laser,Inc. 11.57% of the capital sold short
- GNI Group Ltd. 10.86% of the capital sold short
- Oncolys BioPharma Inc. 10.84% of the capital sold short
- Metaplanet Inc. 10.27% of the capital sold short
- AIMECHATEC,Ltd. 9.68% of the capital sold short
- ReYuu Japan Inc. 9.50% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.49% of the capital sold short
- KLab Inc. 8.85% of the capital sold short
- Astroscale Holdings Inc. 8.80% of the capital sold short
- Hutzper Inc. 8.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Nxera Pharma Co.,Ltd., source JPX, data as at November 2, 2026, https://www.quivad.com/action/nxera-pharma-co-ltd
Embed the chart
<iframe src="https://www.quivad.com/embed/action/nxera-pharma-co-ltd" width="600" height="280" title="Nxera Pharma Co.,Ltd." loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/nxera-pharma-co-ltd"><img src="https://www.quivad.com/action/nxera-pharma-co-ltd/badge.svg" alt="QuiVad, Nxera Pharma Co.,Ltd."></a>